UPDATE: Credit Suisse On uniQure Price Target Raise Earlier: Firm Notes Sufficient Cash Position For Operations Into 1H24 At $677.3M; Focuses On AMT-061 Treatment Of HemB With BLA Submission Expected 1Q22, Sees AMT-130 For Huntington's On Track